NeuroSense Therapeutics (NASDAQ: NRSN) Details PrimeC’s Positive Results from Stage III ALS Biomarker Study
NeuroSense Therapeutics, Inc. (NASDAQ: NRSN) is a clinical-stage biotechnology company, which is focused on the research and development of therapies...
Read more